Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. (새로운 창 열기)

Arnold DM, Fergusson DA, Chan AK, Cook RJ, Fraser GA, Lim W, Blajchman MA, Cook DJ.

Source‎: Anesth Analg 2006;102(3):731-7.

Indexed‎: PubMed 16492820

DOI‎: 10.1213/01.ane.0000194954.64293.61

https://www.ncbi.nlm.nih.gov/pubmed/16492820 (새로운 창 열기)

A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use. (새로운 창 열기)

Basta MN, Stricker PA, Taylor JA.

Source‎: Pediatr Surg Int 2012;28(11):1059-69.

Indexed‎: PubMed 22940882

DOI‎: 10.1007/s00383-012-3167-6

https://www.ncbi.nlm.nih.gov/pubmed/22940882 (새로운 창 열기)

Aprotinin, transfusions, and kidney injury in neonates and infants undergoing cardiac surgery. (새로운 창 열기)

Bojan M, Vicca S, Boulat C, Gioanni S, Pouard P.

Source‎: Br J Anaesth 2012;108(5):830-7.

Indexed‎: PubMed 22362670

DOI‎: 10.1093/bja/aes002

https://www.ncbi.nlm.nih.gov/pubmed/22362670 (새로운 창 열기)

Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. (새로운 창 열기)

Chauhan S, Das SN, Bisoi A, Kale S, Kiran U.

Source‎: J Cardiothorac Vasc Anesth 2004;18(2):141-3.

Indexed‎: PubMed 15073700

https://www.ncbi.nlm.nih.gov/pubmed/15073700 (새로운 창 열기)

Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. (새로운 창 열기)

Chauhan S, Kumar BA, Rao BH, Rao MS, Dubey B, Saxena N, Venugopal P.

Source‎: Ann Thorac Surg 2000;70(4):1308-12.

Indexed‎: PubMed 11081890

https://www.ncbi.nlm.nih.gov/pubmed/11081890 (새로운 창 열기)

The Bayer 022 compassionate-use pediatric study. (새로운 창 열기)

Coniff RF.

Source‎: Ann Thorac Surg 1998;65(6 Suppl):S31-3.

Indexed‎: PubMed 9647135

https://www.ncbi.nlm.nih.gov/pubmed/9647135 (새로운 창 열기)

Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery. (새로운 창 열기)

Graham EM, Atz AM, Gillis J, Desantis SM, Haney AL, Deardorff RL, Uber WE, Reeves ST, McGowan FX Jr, Bradley SM, Spinale FG.

Source‎: J Thorac Cardiovasc Surg 2012;143(5):1069-76.

Indexed‎: PubMed 22075061

DOI‎: 10.1016/j.jtcvs.2011.08.051

https://www.ncbi.nlm.nih.gov/pubmed/22075061 (새로운 창 열기)

Minimizing perioperative blood loss and transfusions in children. [Réduire les pertes sanguines et les besoins transfusionnels en chirurgie pédiatrique.] [English, French abstract] (새로운 창 열기)

Guay J, de Moerloose P, Lasne D.

Source‎: Can J Anaesth 2006;53(6 Suppl):S59-67.

Indexed‎: PubMed 16766791

https://www.ncbi.nlm.nih.gov/pubmed/16766791 (새로운 창 열기)

Intraoperative tranexamic acid in pediatric bloodless cardiac surgery. (새로운 창 열기)

Hasegawa T, Oshima Y, Maruo A, Matsuhisa H, Tanaka A, Noda R, Yokoyama S, Iwasaki K.

Source‎: Asian Cardiovasc Thorac Ann 2014;22(9):1039-45.

Indexed‎: PubMed 24637029

DOI‎: 10.1177/0218492314527991

https://www.ncbi.nlm.nih.gov/pubmed/24637029 (새로운 창 열기)

The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery. (새로운 창 열기)

Lin CY, Shuhaiber JH, Loyola H, Liu H, Del Nido P, DiNardo JA, Pigula FA.

Source‎: PLoS One 2015;10(5):e0126514.

Indexed‎: PubMed 25954976

DOI‎: 10.1371/journal.pone.0126514

https://www.ncbi.nlm.nih.gov/pubmed/25954976 (새로운 창 열기)

Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials. (새로운 창 열기)

Lu J, Meng H, Meng Z, Sun Y, Pribis JP, Zhu C, Li Q.

Source‎: Int J Clin Exp Pathol 2015;8(7):7978-87.

Indexed‎: PubMed 26339364

https://www.ncbi.nlm.nih.gov/pubmed/26339364 (새로운 창 열기)

Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. (새로운 창 열기)

Martin K, Breuer T, Gertler R, Hapfelmeier A, Schreiber C, Lange R, Hess J, Wiesner G.

Source‎: Eur J Cardiothorac Surg 2011;39(6):892-7.

Indexed‎: PubMed 21115357

DOI‎: 10.1016/j.ejcts.2010.09.041

https://www.ncbi.nlm.nih.gov/pubmed/21115357 (새로운 창 열기)

Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome. (새로운 창 열기)

Martin K, Gertler R, MacGuill M, Mayr NP, Hapfelmeier A, Hörer J, Vogt M, Tassani P, Wiesner G.

Source‎: Br J Anaesth 2013;110(4):615-21.

Indexed‎: PubMed 23213034

DOI‎: 10.1093/bja/aes430

https://www.ncbi.nlm.nih.gov/pubmed/23213034 (새로운 창 열기)

Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (새로운 창 열기)

Miller BE, Tosone SR, Tam VK, Kanter KR, Guzzetta NA, Bailey JM, Levy JH.

Source‎: Ann Thorac Surg 1998;66(2):535-40; discussion 541.

Indexed‎: PubMed 9725399

https://www.ncbi.nlm.nih.gov/pubmed/9725399 (새로운 창 열기)

Efficacy of tranexamic acid as compared to aprotinin in open heart surgery in children. (새로운 창 열기)

Muthialu N, Balakrishnan S, Sundar R, Muralidharan S.

Source‎: Ann Card Anaesth 2015;18(1):23-6.

Indexed‎: PubMed 25566706

DOI‎: 10.4103/0971-9784.148316

https://www.ncbi.nlm.nih.gov/pubmed/25566706 (새로운 창 열기)

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (새로운 창 열기)

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

Source‎: J Thorac Cardiovasc Surg 2012;143(3):550-7.

Indexed‎: PubMed 22264414

DOI‎: 10.1016/j.jtcvs.2011.06.048

https://www.ncbi.nlm.nih.gov/pubmed/22264414 (새로운 창 열기)

The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. (새로운 창 열기)

Reid RW, Zimmerman AA, Laussen PC, Mayer JE, Gorlin JB, Burrows FA.

Source‎: Anesth Analg 1997;84(5):990-6.

Indexed‎: PubMed 9141920

https://www.ncbi.nlm.nih.gov/pubmed/9141920 (새로운 창 열기)

Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study. (새로운 창 열기)

Rozen L, Faraoni D, Sanchez Torres C, Willems A, Noubouossie DC, Barglazan D, Van der Linden P, Demulder A.

Source‎: Eur J Anaesthesiol 2015;32(12):844-50.

Indexed‎: PubMed 26258658

DOI‎: 10.1097/EJA.0000000000000316

https://www.ncbi.nlm.nih.gov/pubmed/26258658 (새로운 창 열기)

Comparison of different doses of ε-aminocaproic acid in children for tetralogy of Fallot surgery: clinical efficacy and safety. (새로운 창 열기)

Sarupria A, Makhija N, Lakshmy R, Kiran U.

Source‎: J Cardiothorac Vasc Anesth 2013;27(1):23-9.

Indexed‎: PubMed 22995453

DOI‎: 10.1053/j.jvca.2012.07.001

https://www.ncbi.nlm.nih.gov/pubmed/22995453 (새로운 창 열기)

Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation. (새로운 창 열기)

Verma YS, Chauhan S, Bisoi AK, Gharde P, Kiran U, Das SN.

Source‎: Ann Card Anaesth 2010;13(2):110-5.

Indexed‎: PubMed 20442540

DOI‎: 10.4103/0971-9784.62935

https://www.ncbi.nlm.nih.gov/pubmed/20442540 (새로운 창 열기)

Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. (새로운 창 열기)

Wesley MC, Pereira LM, Scharp LA, Emani SM, McGowan FX Jr, DiNardo JA.

Source‎: Anesthesiology 2015;122(4):746-58.

Indexed‎: PubMed 25585004

DOI‎: 10.1097/ALN.0000000000000570

https://www.ncbi.nlm.nih.gov/pubmed/25585004 (새로운 창 열기)

Efficacy and safety of aprotinin in neonatal congenital heart operations. (새로운 창 열기)

Wilder NS, Kavarana MN, Voepel-Lewis T, Paugh T, Lee T, Ohye RG.

Source‎: Ann Thorac Surg 2011;92(3):958-63.

Indexed‎: PubMed 21871283

DOI‎: 10.1016/j.athoracsur.2011.04.094

https://www.ncbi.nlm.nih.gov/pubmed/21871283 (새로운 창 열기)

The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. (새로운 창 열기)

Zonis Z, Seear M, Reichert C, Sett S, Allen C.

Source‎: J Thorac Cardiovasc Surg 1996;111(5):982-7.

Indexed‎: PubMed 8622323

https://www.ncbi.nlm.nih.gov/pubmed/8622323 (새로운 창 열기)

Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. (새로운 창 열기)

Agarwal HS, Bennett JE, Churchwell KB, Christian KG, Drinkwater DC Jr, He Y, Taylor MB.

Source‎: Ann Thorac Surg 2007;84(1):161-8.

Indexed‎: PubMed 17588404

DOI‎: 10.1016/j.athoracsur.2007.02.051

https://www.ncbi.nlm.nih.gov/pubmed/17588404 (새로운 창 열기)

Pediatric off-label use of recombinant factor VIIa. (새로운 창 열기)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

Source‎: Pediatrics 2009;123(3):1066-72.

Indexed‎: PubMed 19255041

DOI‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (새로운 창 열기)

Factor VII for excessive bleeding following congenital heart disease surgery. (새로운 창 열기)

Changlani DK, Devendaran V, Murmu UC, Ganesan S, Varghese R, Kumar RS.

Source‎: Asian Cardiovasc Thorac Ann 2012;20(2):120-5.

Indexed‎: PubMed 22499956

DOI‎: 10.1177/0218492311433614

https://www.ncbi.nlm.nih.gov/pubmed/22499956 (새로운 창 열기)

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (새로운 창 열기)

Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.

Source‎: Paediatr Anaesth 2009;19(4):364-70.

Indexed‎: PubMed 19143947

DOI‎: 10.1111/j.1460-9592.2008.02905.x

https://www.ncbi.nlm.nih.gov/pubmed/19143947 (새로운 창 열기)

Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. (새로운 창 열기)

Guzzetta NA, Russell IA, Williams GD.

Source‎: Anesth Analg 2012;115(2):364-78.

Indexed‎: PubMed 22652310

DOI‎: 10.1213/ANE.0b013e31825aff10

https://www.ncbi.nlm.nih.gov/pubmed/22652310 (새로운 창 열기)

Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery? (새로운 창 열기)

Okonta KE, Edwin F, Falase B.

Source‎: Interact Cardiovasc Thorac Surg 2012;15(4):690-4.

Indexed‎: PubMed 22811512

DOI‎: 10.1093/icvts/ivs309

https://www.ncbi.nlm.nih.gov/pubmed/22811512 (새로운 창 열기)

Cardiac surgery without blood products in a Jehovah's Witness child with factor VII deficiency. (새로운 창 열기)

Pérez-Ferrer A, Gredilla E, de Vicente J, Laporta Y.

Source‎: J Cardiothorac Vasc Anesth 2012;26(4):651-3.

Indexed‎: PubMed 21924639

DOI‎: 10.1053/j.jvca.2011.07.012

https://www.ncbi.nlm.nih.gov/pubmed/21924639 (새로운 창 열기)

Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. (새로운 창 열기)

Pychyńska-Pokorska M, Pągowska-Klimek I, Krajewski W, Moll JJ.

Source‎: J Cardiothorac Vasc Anesth 2011;25(6):987-94.

Indexed‎: PubMed 21835642

DOI‎: 10.1053/j.jvca.2011.05.012

https://www.ncbi.nlm.nih.gov/pubmed/21835642 (새로운 창 열기)

Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery. (새로운 창 열기)

Scott JP, Costigan DJ, Hoffman GM, Simpson PM, Dasgupta M, Punzalan R, Berens RJ, Tweddell JS, Stuth EA.

Source‎: J Clin Anesth 2014;26(3):204-11.

Indexed‎: PubMed 24809789

DOI‎: 10.1016/j.jclinane.2013.10.015

https://www.ncbi.nlm.nih.gov/pubmed/24809789 (새로운 창 열기)

Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery. (새로운 창 열기)

Singh SP, Chauhan S, Choudhary M, Vasdev S, Talwar S.

Source‎: Asian Cardiovasc Thorac Ann 2012;20(1):19-23.

Indexed‎: PubMed 22371937

DOI‎: 10.1177/0218492311432584

https://www.ncbi.nlm.nih.gov/pubmed/22371937 (새로운 창 열기)

Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. (새로운 창 열기)

Tobias JD, Berkenbosch JW, Russo P.

Source‎: Pediatr Crit Care Med 2003;4(1):49-51.

Indexed‎: PubMed 12656542

DOI‎: 10.1097/01.PCC.0000031472.55687.4E

https://www.ncbi.nlm.nih.gov/pubmed/12656542 (새로운 창 열기)

Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. (새로운 창 열기)

Tobias JD, Simsic JM, Weinstein S, Schechter W, Kartha V, Michler R.

Source‎: J Intensive Care Med 2004;19(5):270-3.

Indexed‎: PubMed 15358945

DOI‎: 10.1177/0885066604267783

https://www.ncbi.nlm.nih.gov/pubmed/15358945 (새로운 창 열기)

Recombinant activated factor VII in cardiac surgery: a systematic review. (새로운 창 열기)

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

Source‎: Ann Thorac Surg 2007;83(2):707-14.

Indexed‎: PubMed 17258029

DOI‎: 10.1016/j.athoracsur.2006.10.033

https://www.ncbi.nlm.nih.gov/pubmed/17258029 (새로운 창 열기)

Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here? (새로운 창 열기)

Warren OJ, Rogers PL, Watret AL, de Wit KL, Darzi AW, Gill R, Athanasiou T.

Source‎: Pediatr Crit Care Med 2009;10(5):572-82.

Indexed‎: PubMed 19451849

DOI‎: 10.1097/PCC.0b013e3181a642d5

https://www.ncbi.nlm.nih.gov/pubmed/19451849 (새로운 창 열기)

Decreasing the need for transfusion: infant cardiac surgery using hemodilution and recombinant factor VIIa. (새로운 창 열기)

Winch PD, Naguib AN, Bradshaw JR, Galantowicz M, Tobias JD.

Source‎: Pediatr Cardiol 2013;34(1):119-24.

Indexed‎: PubMed 22760694

DOI‎: 10.1007/s00246-012-0398-1

https://www.ncbi.nlm.nih.gov/pubmed/22760694 (새로운 창 열기)

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (새로운 창 열기)

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

Source‎: Pediatr Hematol Oncol 2008;25(4):301-11.

Indexed‎: PubMed 18484474

DOI‎: 10.1080/08880010802016904

https://www.ncbi.nlm.nih.gov/pubmed/18484474 (새로운 창 열기)

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (새로운 창 열기)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Source‎: Artif Organs 2010;34(11):955-60.

Indexed‎: PubMed 21092037

DOI‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (새로운 창 열기)

Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. (새로운 창 열기)

Faraoni D, Willems A, Savan V, Demanet H, De Ville A, Van der Linden P.

Source‎: Eur J Anaesthesiol 2014;31(6):317-26.

Indexed‎: PubMed 24503704

DOI‎: 10.1097/EJA.0000000000000043

https://www.ncbi.nlm.nih.gov/pubmed/24503704 (새로운 창 열기)

Efficacy and safety of fibrinogen concentrate in surgical patients: a meta-analysis of randomized controlled trials. (새로운 창 열기)

Fominskiy E, Nepomniashchikh VA, Lomivorotov VV, Monaco F, Vitiello C, Zangrillo A, Landoni G.

Source‎: J Cardiothorac Vasc Anesth 2016;30(5):1196-204.

Indexed‎: PubMed 27493092

DOI‎: 10.1053/j.jvca.2016.04.015

https://www.ncbi.nlm.nih.gov/pubmed/27493092 (새로운 창 열기)

Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial. (새로운 창 열기)

Galas FR, de Almeida JP, Fukushima JT, Vincent JL, Osawa EA, Zeferino S, Câmara L, Guimarães VA, Jatene MB, Hajjar LA.

Source‎: J Thorac Cardiovasc Surg 2014;148(4):1647-55.

Indexed‎: PubMed 24951020

DOI‎: 10.1016/j.jtcvs.2014.04.029

https://www.ncbi.nlm.nih.gov/pubmed/24951020 (새로운 창 열기)

Four-factor prothrombin complex concentrates in paediatric patients—a retrospective case series. (새로운 창 열기)

Noga T, Bruce AA, Blain H, Nahirniak S.

Source‎: Vox Sang 2016;110(3):253-7.

Indexed‎: PubMed 26509839

DOI‎: 10.1111/vox.12353

https://www.ncbi.nlm.nih.gov/pubmed/26509839 (새로운 창 열기)

Minimizing perioperative blood loss and transfusions in children. [Réduire les pertes sanguines et les besoins transfusionnels en chirurgie pédiatrique.] [English, French abstract] (새로운 창 열기)

Guay J, de Moerloose P, Lasne D.

Source‎: Can J Anaesth 2006;53(6 Suppl):S59-67.

Indexed‎: PubMed 16766791

https://www.ncbi.nlm.nih.gov/pubmed/16766791 (새로운 창 열기)

Anesthetic management in a pediatric patient with Noonan syndrome, mastocytosis, and von Willebrand disease: a case report. (새로운 창 열기)

Macksey LF, White B.

Source‎: AANA J 2007;75(4):261-4.

Indexed‎: PubMed 17711156

https://www.ncbi.nlm.nih.gov/pubmed/17711156 (새로운 창 열기)

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (새로운 창 열기)

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

Source‎: Ann Surg 2010;251(2):217-28.

Indexed‎: PubMed 20010084

DOI‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 (새로운 창 열기)

Resternotomy in pediatric cardiac surgery: CoSeal initial experience. (새로운 창 열기)

Pace Napoleone C, Oppido G, Angeli E, Gargiulo G.

Source‎: Interact Cardiovasc Thorac Surg 2007;6(1):21-3.

Indexed‎: PubMed 17669759

DOI‎: 10.1510/icvts.2006.141531

https://www.ncbi.nlm.nih.gov/pubmed/17669759 (새로운 창 열기)

Utility of Sonoclot analysis and tranexamic acid in tetralogy of Fallot patients undergoing intracardiac repair. (새로운 창 열기)

Aggarwal V, Kapoor PM, Choudhury M, Kiran U, Chowdhury U.

Source‎: Ann Card Anaesth 2012;15(1):26-31.

Indexed‎: PubMed 22234018

DOI‎: 10.4103/0971-9784.91477

https://www.ncbi.nlm.nih.gov/pubmed/22234018 (새로운 창 열기)

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (새로운 창 열기)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Source‎: Artif Organs 2010;34(11):955-60.

Indexed‎: PubMed 21092037

DOI‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (새로운 창 열기)

Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. (새로운 창 열기)

Nakayama Y, Nakajima Y, Tanaka KA, Sessler DI, Maeda S, Iida J, Ogawa S, Mizobe T.

Source‎: Br J Anaesth 2015;114(1):91-102.

Indexed‎: PubMed 25303988

DOI‎: 10.1093/bja/aeu339

https://www.ncbi.nlm.nih.gov/pubmed/25303988 (새로운 창 열기)